Immunic (IMUX) Shares Outstanding (2013 - 2026)

Immunic (IMUX) has 6 years of Shares Outstanding (Entity) data on file, last reported at $772227.0 in Q4 2019.

• For the quarter ending Q4 2019, Shares Outstanding (Entity) rose 629.04% year-over-year to $772227.0; the trailing twelve-month figure through Dec 2019 stood at $772227.0 (up 629.04% YoY), and the FY2019 full-year result was $772227.0, up 629.04% from the prior year.
• Shares Outstanding (Entity) declined to $772227.0 in Q4 2019, from $1.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.0 million in Q3 2019 to a low of $60026.0 in Q1 2015.
• A 5-year average of $213298.0 and a median of $105518.0 in 2017 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 0.0% in 2018 and jumped 850.75% in 2019, its largest moves.
• Tracing IMUX's Shares Outstanding (Entity) over 5 years: stood at $62882.0 in 2015, then gained by 27.79% to $80359.0 in 2016, then surged by 31.81% to $105922.0 in 2017, then climbed by 0.0% to $105924.0 in 2018, then surged by 629.04% to $772227.0 in 2019.
• Business Quant data shows IMUX's Shares Outstanding (Entity) at $772227.0 in Q4 2019, $1.0 million in Q3 2019, and $998640.0 in Q2 2019.